Evidence map›Paper›PMID 34451497›Full record

ArticlePathogens (Basel, Switzerland)2021

Antibiofilm and Antimicrobial-Enhancing Activity of

Paweł Krzyżek, Adam Junka, Wojciech Słupski, Arleta Dołowacka-Jóźwiak, Bartosz J Płachno, Aleksandra Sobiecka, Adam Matkowski, Grzegorz Chodaczek, Tadeusz Płusa, Grażyna Gościniak and 1 more

Open access · goldAbstract read
In one paragraph

Article in Pathogens (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 22 papers.

0numbers the graph read from it
0cells of the map it votes in
22citing papers in PubMed
3.7field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

22 citing papers in PubMed, 30 citations in OpenAlex.

  1. Molecular and Pharmacokinetic Rationale for the Use ofMolecules (Basel, Switzerland) · 2026
    Article
  2. Article
  3. Plants (Basel, Switzerland) · 2025
    Review
  4. Anti-Molecules (Basel, Switzerland) · 2025
    Article
  5. Antitumor Alkaloids in Tibetan Corydalis: Chemical Diversity and Pharmacological Insights.Medical science monitor : international medical journal of experimental and clinical research · 2025
    Review
  6. Towards EffectiveInternational journal of molecular sciences · 2025
    Review
  7. Bioactive Properties ofPlants (Basel, Switzerland) · 2024
    Article
  8. Opportunities forMicroorganisms · 2024
    Review
  9. Review
  10. Romanian Wild-GrowingPlants (Basel, Switzerland) · 2024
    Article
  11. The effects and mechanisms of natural products onFrontiers in cellular and infection microbiology · 2024
    Review
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Chemical Composition and In Vitro Anti-Plants (Basel, Switzerland) · 2022
    Article
  18. Article
  19. Infection and drug resistance · 2022
    Review
  20. Phillygenin InhibitsFrontiers in microbiology · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 4 institutions in 1 country.

Paweł KrzyżekDepartment of Medical Microbiology, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0002-3117-8894
Adam JunkaDepartment of Pharmaceutical Microbiology and Parasitology, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-7559-8903
Wojciech SłupskiDepartment of Pharmacology, Wroclaw Medical University, 50-345 Wrocław, Poland.
Arleta Dołowacka-JóźwiakDepartment of Drug Form Technology, Wroclaw Medical University, 50-556 Wroclaw, Poland.
Bartosz J PłachnoDepartment of Plant Cytology and Embryology, Institute of Botany, Faculty of Biology, Jagiellonian University in Cracow, 9 Gronostajowa St., 30-387 Cracow, Poland.ORCID 0000-0001-5579-5101
Aleksandra SobieckaDepartment of Pharmaceutical Biotechnology, Wroclaw Medical University, 50-556 Wrocław, Poland.
Adam MatkowskiDepartment of Pharmaceutical Biology and Botanical Garden of Medicinal Plants, Wroclaw Medical University, 50-556 Wroclaw, Poland.ORCID 0000-0002-7283-2653
Grzegorz ChodaczekBioimaging Laboratory, Łukasiewicz Research Network-PORT Polish Center for Technology Development, 54-066 Wroclaw, Poland.
Tadeusz PłusaFaculty of Medicine, Lazarski University, 02-662 Warszawa, Poland.ORCID 0000-0002-4949-7834
Grażyna GościniakDepartment of Medical Microbiology, Wroclaw Medical University, 50-368 Wroclaw, Poland.ORCID 0000-0001-6597-9609
Sylwia ZielińskaDepartment of Pharmaceutical Biotechnology, Wroclaw Medical University, 50-556 Wrocław, Poland.ORCID 0000-0003-0090-5486
Wroclaw Medical University · PLJagiellonian University · PLŁukasiewicz Research Network – PORT Polish Center for Technology Development · PLUczelnia Łazarskiego · PL

Funding

Ministerstwo Nauki i Szkolnictwa Wyższego 96/E394/SPUB/SP/2019Narodowe Centrum Badań i Rozwoju IA/SP/453975/2020Narodowym Centrum Nauki 2019/35/D/NZ7/00266Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu SUB.A130.21.031Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu SUB.D230.20.002
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

3-bromopyruvateamoxicillinbacterial cellulosebiofilmBiofluxflow systemHelicobacter pyloriPapaveraceaesertralinesynergism

Identifiers

PMID34451497
PMCPMC8400265
OpenAlexW3193288231

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.